The safety of quinolones and fluoroquinolones in pregnancy: a meta-analysis
- PMID: 29319210
- DOI: 10.1111/1471-0528.15119
The safety of quinolones and fluoroquinolones in pregnancy: a meta-analysis
Abstract
Background: Quinolones were contraindicated during pregnancy because of concerns regarding fetal malformations and carcinogenesis in animals. The literature is conflicting regarding their safety in humans.
Objectives: To conduct a meta-analysis evaluating the risk for fetal malformations and pregnancy complications following exposure to quinolones during pregnancy.
Search strategy: We searched Embase, PubMed, Medline, the Cochrane database, clinicaltrials.gov, and Dart Databases. We added articles found through the references of included articles.
Selection criteria: Relevant English citations using the terms quinolone/s, fluoroquinolone/s, and pregnancy in humans. Exclusion criteria were case reports, reviews, and articles without data regarding the study outcomes.
Data collection and analysis: Two authors performed the database search, assessment of eligibility, and abstraction of data from included studies. Disagreement was settled by consensus among all authors. The pooled odds ratios (with 95% CIs) were estimated. The Cochrane's Q-test of heterogeneity and I² were used for the measurement of heterogeneity. A total of 256 papers were retrieved, 13 of which met the inclusion criteria and were then analysed.
Main results: No association was found between quinolones and fetal malformations (pooled odds ratio, OR 1.08; 95% CI 0.96-1.21), preterm delivery (pooled OR 0.97; 95% CI 0.75-1.24), stillbirth (pooled OR 1.11; 95% CI 0.34-3.6), or miscarriage (pooled OR 1.78; 95% CI 0.93-3.38).
Conclusions: Quinolones are not associated with unfavourable pregnancy outcomes; however, larger studies are needed before safety is established. Until then, it is suggested that quinolones should not be used as a first-line therapy during the first trimester.
Tweetable abstract: Quinolones were associated with favourable pregnancy outcomes; caution should be taken in the first trimester.
Keywords: fetal malformations; miscarriages; pregnancy; quinolones; stillbirth; terminations of pregnancy.
© 2018 Royal College of Obstetricians and Gynaecologists.
Similar articles
-
Pregnancy Outcomes Following Exposure to Quinolone Antibiotics - a Systematic-Review and Meta-Analysis.Pharm Res. 2018 Mar 26;35(5):109. doi: 10.1007/s11095-018-2383-8. Pharm Res. 2018. PMID: 29582196
-
The safety of quinolones--a meta-analysis of pregnancy outcomes.Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):75-8. doi: 10.1016/j.ejogrb.2008.12.007. Epub 2009 Jan 31. Eur J Obstet Gynecol Reprod Biol. 2009. PMID: 19181435 Review.
-
Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta-analysis.Pharmacol Res Perspect. 2020 Oct;8(5):e00644. doi: 10.1002/prp2.644. Pharmacol Res Perspect. 2020. PMID: 32815286 Free PMC article.
-
A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan.Congenit Anom (Kyoto). 2025 Jan-Dec;65(1):e12588. doi: 10.1111/cga.12588. Congenit Anom (Kyoto). 2025. PMID: 39617399
-
Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: A systematic review and meta-analysis.Reprod Toxicol. 2019 Apr;85:65-74. doi: 10.1016/j.reprotox.2019.02.002. Epub 2019 Feb 7. Reprod Toxicol. 2019. PMID: 30738954
Cited by
-
Diverticulitis during pregnancy: A review of the reported cases.Front Med (Lausanne). 2022 Nov 11;9:942666. doi: 10.3389/fmed.2022.942666. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36438049 Free PMC article.
-
Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review.Clin Infect Dis. 2022 Oct 17;75(Suppl 3):S417-S431. doi: 10.1093/cid/ciac592. Clin Infect Dis. 2022. PMID: 36251549 Free PMC article. Review.
-
Quinolone Use during the First Trimester of Pregnancy and the Risk of Atopic Dermatitis, Asthma, and Allergies of Offspring during 2011 to 2020.Infect Chemother. 2024 Dec;56(4):461-472. doi: 10.3947/ic.2024.0030. Epub 2024 Sep 11. Infect Chemother. 2024. PMID: 39431345 Free PMC article.
-
Advancing Glaucoma Treatment During Pregnancy and Breastfeeding: Contemporary Management Strategies and Prospective Therapeutic Developments.Biomedicines. 2024 Nov 25;12(12):2685. doi: 10.3390/biomedicines12122685. Biomedicines. 2024. PMID: 39767592 Free PMC article. Review.
-
Pregnancy related adverse events and congenital disorders associated with fluoroquinolones: A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).Heliyon. 2024 Sep 7;10(18):e37547. doi: 10.1016/j.heliyon.2024.e37547. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39309803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous